Metaglip

Active Ingredient(s): Glipizide + Metformin
FDA Approved: * October 21, 2002
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Metaglip Overview

Glipizide, sold under the trade name Glucotrol among others, is an anti-diabetic medication of the sulfonylurea class used to treat type 2 diabetes.[1] It is used together with a diabetic diet.[1] It is not indicated for use by itself in type 1 diabetes.[1] It is taken by mouth.[1] Effects generally begin within half an hour and can last for up to a day.[1] Common side effects include nausea, diarrhea, low blood s...

Read more Metaglip Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glipizide

Recent Metaglip Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Glipizide + Metformin
  • Tablet: 2.5mg + 250mg, 2.5mg + 500mg, 5mg + 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (42 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA